MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain. [electronic resource]
Producer: 20040628Description: 525-32 p. digitalISSN:- 0340-7004
- Animals
- Antigen Presentation
- Antigens, Differentiation, B-Lymphocyte -- immunology
- B7-1 Antigen -- genetics
- CD4-Positive T-Lymphocytes -- immunology
- Cancer Vaccines -- immunology
- Chickens
- Egg White
- Female
- Genes, MHC Class II -- genetics
- Histocompatibility Antigens Class II -- immunology
- Interferon-gamma -- metabolism
- Interleukin-2 -- metabolism
- Interleukin-4 -- metabolism
- Lymphocyte Activation
- Mice
- Mice, Inbred C3H
- Mice, Inbred CBA
- Mice, Transgenic
- Muramidase -- administration & dosage
- Sarcoma, Experimental -- immunology
- Transgenes
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.